Pregabalin augmentation to antidepressants in patients with major depressive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 3, 2009, Pages 577-578

  Pae, Chi Un ^a,b  

^a The Catholic University of Korea   (South Korea)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; ESCITALOPRAM; MILNACIPRAN; MIRTAZAPINE; PAROXETINE; PREGABALIN; VENLAFAXINE;

ADULT; CASE REPORT; COMBINATION CHEMOTHERAPY; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; LETTER; MAJOR DEPRESSION; TREATMENT OUTCOME;

ADULT; ANALGESICS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DRUG SYNERGISM; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MIDDLE AGED;

EID: 62849085492     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.02.001     Document Type: Letter

References (14)

1. Arnold L.M., Russell I.J., Diri E.W., Duan W.R., Young Jr. J.P., Sharma U., et al. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 9 (2008) 792-805
2. Bhagwagar Z., Wylezinska M., Taylor M., Jezzard P., Matthews P.M., and Cowen P.J. Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry 161 (2004) 368-370
3. Brodie M.J., Wilson E.A., Wesche D.L., Alvey C.W., Randinitis E.J., Posvar E.L., et al. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy. Epilepsia 46 (2005) 1407-1413
4. Feltner D.E., Crockatt J.G., Dubovsky S.J., Cohn C.K., Shrivastava R.K., Targum S.D., et al. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol 23 (2003) 240-249
5. Gajraj N.M. Pregabalin: its pharmacology and use in pain management. Anesth Analg 105 (2007) 1805-1815
6. Krystal J.H., Sanacora G., Blumberg H., Anand A., Charney D.S., Marek G., et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 7 Suppl 1 (2002) S71-80
7. Lodge N.J., and Li Y.W. Ion channels as potential targets for the treatment of depression. Curr Opin Drug Discov Devel 11 (2008) 633-641
8. Owen R.T. Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety. Drugs Today (Barc) 43 (2007) 601-610
9. Pae C.U., Luyten P., Marks D.M., Han C., Park S.H., Patkar A.A., et al. The relationship between fibromyalgia and major depressive disorder: a comprehensive review. Curr Med Res Opin 24 (2008) 2359-2371
10. Pae C.U., Marks D.M., Han C., Masand P.S., and Patkar A.A. Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study. Int Clin Psychopharmacol 24 (2009) 29-33
11. Sanacora G., Mason G.F., Rothman D.L., and Krystal J.H. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 159 (2002) 663-665
12. Sanacora G., Fenton L.R., Fasula M.K., Rothman D.L., Levin Y., Krystal J.H., et al. Cortical gamma-aminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy. Biol Psychiatry 59 (2006) 284-286
13. Showraki M. Pregabalin in the treatment of depression. J Psychopharmacol 21 (2007) 883-884
14. Stein D.J., Baldwin D.S., Baldinetti F., and Mandel F. Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies. Eur Neuropsychopharmacol 18 (2008) 422-430